Federation des caisses Desjardins du Quebec’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5K | Buy |
+2,394
| New | +$21.5K | ﹤0.01% | 1794 |
|
|
2021
Q3 | – | Sell |
-4,800
| Closed | -$75.9K | – | 2559 |
|
|
2021
Q2 | $75.9K | Sell |
4,800
-3,000
| -38% | -$47.4K | ﹤0.01% | 1482 |
|
|
2021
Q1 | $79.3K | Sell |
7,800
-6,200
| -44% | -$63.1K | ﹤0.01% | 1411 |
|
|
2020
Q4 | $104K | Buy |
+14,000
| New | +$104K | ﹤0.01% | 1267 |
|
|
2020
Q3 | – | Sell |
-6,200
| Closed | -$29.5K | – | 2167 |
|
|
2020
Q2 | $29.5K | Buy |
+6,200
| New | +$29.5K | ﹤0.01% | 1345 |
|
|
2018
Q2 | – | Sell |
-43,502
| Closed | -$207K | – | 2157 |
|
|
2018
Q1 | $207K | Sell |
43,502
-15,005
| -26% | -$71.4K | ﹤0.01% | 1006 |
|
|
2017
Q4 | $287K | Hold |
58,507
| – | – | ﹤0.01% | 953 |
|
|
2017
Q3 | $307K | Buy |
58,507
+24,619
| +73% | +$129K | ﹤0.01% | 907 |
|
|
2017
Q2 | $188K | Buy |
+33,888
| New | +$188K | ﹤0.01% | 1020 |
|